Eli Lilly vet takes helm at Brickell Biotech; Stemline's Elzonris secures speedy EU review
→ Brickell Biotech has hired industry veteran and Lilly $LLY Chief Marketing Officer Robert Brown to take over the reins at the dermatology company as it preps a late-stage trial evaluating its drug, sofpironium bromide, in patients with excessive underarm sweating in the first half of 2019. Brown, who has spent over three decades at Lilly, is set to replace Brickell’s current CEO and co-founder Reginald Hardy on January 1.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.